These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7818926)

  • 1. Carboplatin and etoposide in extensive small cell lung cancer.
    Viren M; Liippo K; Ojala A; Helle L; Hinkka S; Huovinen R; Jakobsson M; Järvinen M; Paloheimo S; Salmi R
    Acta Oncol; 1994; 33(8):921-4. PubMed ID: 7818926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paclitaxel, carboplatin, and extended-schedule etoposide in the treatment of small-cell lung cancer: comparison of sequential phase II trials using different dose-intensities.
    Hainsworth JD; Gray JR; Stroup SL; Kalman LA; Patten JE; Hopkins LG; Thomas M; Greco FA
    J Clin Oncol; 1997 Dec; 15(12):3464-70. PubMed ID: 9396399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is carboplatin and oral etoposide an effective and feasible regimen in patients with small cell lung cancer?
    Pfeiffer P; Sørensen P; Rose C
    Eur J Cancer; 1995; 31A(1):64-9. PubMed ID: 7695981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paclitaxel, carboplatin, and extended schedule etoposide in the treatment of small cell lung carcinoma.
    Hainsworth JD; Stroup SL; Greco FA
    Cancer; 1996 Jun; 77(12):2458-63. PubMed ID: 8640693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of extensive small cell lung cancer with carboplatin and teniposide.
    Sørensen BT; Nielsen K; Steenholdt S; Schultz H; Jakobsen A
    Eur J Cancer; 1991; 27(9):1109-12. PubMed ID: 1659851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I trial of etoposide, carboplatin, and GM-CSF in extensive small-cell lung cancer: a Cancer and Leukemia Group B study (CALGB 8832).
    Luikart SD; Herndon JE; Hollis DR; MacDonald M; Maurer LH; Crawford J; Clamon GH; Wright J; Perry MC; Ozer H; Green MR
    Am J Clin Oncol; 1997 Feb; 20(1):24-30. PubMed ID: 9020283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose intensity phase I/II trial with carboplatin, ifosfamide, etoposide and vincristine combined with filgrastim in patients with small-cell lung cancer.
    Hanauske AR; Korfel A; Perker M; Heinrich B; Schwab G; Graf M; Depenbrock H; Höffken G; Kreuser ED; Thiel E; Zwingers T; Berdel WE
    Oncology; 1997; 54(5):363-70. PubMed ID: 9260596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etoposide, carboplatin, cyclophosphamide and vincristine in previously untreated patients with small-cell lung cancer.
    Bishop JF; Kefford R; Raghavan D; Zalcberg J; Stuart-Harris R; Ball D; Olver IN; Friedlander M; Bull C; Yuen K
    Cancer Chemother Pharmacol; 1990; 25(5):367-70. PubMed ID: 2155064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of ifosfamide, carboplatin, and oral etoposide chemotherapy for extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group pilot study.
    Wolff AC; Ettinger DS; Neuberg D; Comis RL; Ruckdeschel JC; Bonomi PD; Johnson DH
    J Clin Oncol; 1995 Jul; 13(7):1615-22. PubMed ID: 7602350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized phase III trial of paclitaxel, etoposide, and carboplatin versus carboplatin, etoposide, and vincristine in patients with small-cell lung cancer.
    Reck M; von Pawel J; Macha HN; Kaukel E; Deppermann KM; Bonnet R; Ulm K; Hessler S; Gatzemeier U
    J Natl Cancer Inst; 2003 Aug; 95(15):1118-27. PubMed ID: 12902441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carboplatin plus etoposide for extensive stage small-cell lung cancer: an experience with AUC 6 doses of carboplatin.
    Yilmaz U; Polat G; Anar C; Halilcolar H
    Indian J Cancer; 2011; 48(4):454-9. PubMed ID: 22293260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etoposide/vincristine-based chemotherapy with or without carboplatin in extensive-stage small cell lung cancer: a prospective randomized phase III trial.
    Gatzemeier U; Pawel JV; Laumen R; Hossfeld DK; Neuhauss R
    Semin Oncol; 1994 Jun; 21(3 Suppl 6):31-5. PubMed ID: 8052871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer: update and preliminary survival analysis.
    Strauss GM; Lynch TJ; Elias AD; Jacobs C; Herbst R; Leong T; Lynch C; Kwiatkowski DJ; Carey RW; Grossbard ML; Skarin AT
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-73-S12-80. PubMed ID: 9331127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of combination chemotherapy with cisplatin, carboplatin and etoposide in stage IIIB and IV small-cell lung cancer. Fukuoka Lung Cancer Study Group.
    Nakanishi Y; Kawarada Y; Hirose N; Ninomiya K; Miyazaki M; Miyazaki N; Kurita Y; Kanegae H; Ohgushi O; Ogata K; Yamazaki H; Inutsuka S; Hara N
    Cancer Chemother Pharmacol; 1998; 41(6):453-6. PubMed ID: 9554588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase I trial of carboplatin and etoposide for elderly (>or=75 year-old) patients with small-cell lung cancer.
    Fukuda M; Soda H; Soejima Y; Fukuda M; Kinoshita A; Takatani H; Kasai T; Nagashima S; Kawabata S; Doi S; Kohno S; Oka M
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):601-6. PubMed ID: 16463061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of area under the plasma-concentration-versus-time curve-based carboplatin plus standard-dose intravenous etoposide in elderly patients with small-cell lung cancer.
    Okamoto H; Watanabe K; Nishiwaki Y; Mori K; Kurita Y; Hayashi I; Masutani M; Nakata K; Tsuchiya S; Isobe H; Saijo N
    J Clin Oncol; 1999 Nov; 17(11):3540-5. PubMed ID: 10550152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel, carboplatin, and oral etoposide in the treatment of small cell lung cancer.
    Greco FA; Hainsworth JD
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):7-10. PubMed ID: 9007113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I/II trial of etoposide and carboplatin in extensive small-cell lung cancer. A report from the Cancer and Leukemia Group B.
    Luikart SD; Goutsou M; Mitchell ED; Van Echo DA; Modeas CR; Propert KJ; O'Donnell J; Difino S; Perry MC; Green MR
    Am J Clin Oncol; 1993 Apr; 16(2):127-31. PubMed ID: 8383914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carboplatin calculated with Chatelut's formula plus etoposide for elderly patients with small-cell lung cancer.
    Matsui K; Masuda N; Yana T; Takada Y; Kobayashi M; Nitta T; Hirashima T; Fukuoka M
    Intern Med; 2001 Jul; 40(7):603-6. PubMed ID: 11506300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combination chemotherapy with carboplatin and etoposide for elderly patients aged 76 years or older with small cell lung cancer].
    Tada A; Ueoka H; Kiura K; Tabata M; Takemoto M; Yamane H; Hiyama J; Aoe K; Shibayama T; Kamei H; Kawahara S; Harita S; Sato T; Kobayashi M; Eguchi K; Hiraki S; Hiraki Y; Tanimoto M
    Gan To Kagaku Ryoho; 2002 May; 29(5):751-6. PubMed ID: 12040679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.